Abstract:Cancer is a borderless global health challenge that continues to threaten human health. Studies have found that oxidative stress (OS) is often associated with the etiology of many diseases, especially the aging process and cancer. Involved in the OS reaction as a key transcription factor, Nrf2 is a pivotal regulator of cellular redox state and detoxification. Nrf2 can prevent oxidative damage by regulating gene expression with antioxidant response elements (ARE) to promote the antioxidant response process. OS is generated with an imbalance in the redox state and promotes the accumulation of mutations and genome instability, thus associated with the establishment and development of different cancers. Nrf2 activation regulates a plethora of processes inducing cellular proliferation, differentiation and death, and is strongly associated with OS-mediated cancer. What's more, Nrf2 activation is also involved in anti-inflammatory effects and metabolic disorders, neurodegenerative diseases, and multidrug resistance. Nrf2 is highly expressed in multiple human body parts of digestive system, respiratory system, reproductive system and nervous system. In oncology research, Nrf2 has emerged as a promising therapeutic target. Therefore, certain natural compounds and drugs can exert anti-cancer effects through the Nrf2 signaling pathway, and blocking the Nrf2 signaling pathway can reduce some types of tumor recurrence rates and increase sensitivity to chemotherapy. However, Nrf2's dual role and controversial impact in cancer are inevitable consideration factors when treating Nrf2 as a therapeutic target. In this review, we summarized the current state of biological characteristics of Nrf2 and its dual role and development mechanism in different tumor cells, discussed Keap1/Nrf2/ARE signaling pathway and its downstream genes, elaborated the expression of related signaling pathways such as AMPK/mTOR and NF-κB. Besides, the main mechanism of Nrf2 as a cancer therapeutic target and the therapeutic strategies using Nrf2 inhibitors or activators, as well as the possible positive and negative effects of Nrf2 activation were also reviewed. It can be concluded that Nrf2 is related to OS and serves as an important factor in cancer formation and development, thus provides a basis for targeted therapy in human cancers.

New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases

The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases

The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs

[Role of Nrf2/HO-1 Signal Axis in the Mechanisms for Oxidative Stress-Relevant Diseases].

An Update on the Role of Nrf2 in Respiratory Disease: Molecular Mechanisms and Therapeutic Approaches

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases

Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.

Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application

The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches

A Protective Role of Nrf2 in Inflammatory Disorders

Oxidative stress and ROS-mediated cellular events in RSV infection: potential protective roles of antioxidants

Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases

Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update

The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches

Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer

Progress on Antioxidant Transcription Factor-Nrf2

Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches

NRF2 inhibitors: Recent progress, future design and therapeutic potential

Regulation of Keap1-Nrf2 signaling in health and diseases